RGP induced DCs maturation and activated antigen-specific immune responses in tumor-bearing mice, causing significant increases in CD4+ and CD8+ T cells, increased mRNA levels of the transcription factor T-BET in Th1 cells, and promoted CSFE-labeled OT-I and OT-II T cells to infiltrate the tumor. The gene discussed is CD8A; the disease is neoplasm.